| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/30/2004 | CA2743539A1 Angiotensin-converting enzyme inhibitory peptides |
| 09/30/2004 | CA2743313A1 Angiotensin-converting enzyme inhibitory peptides |
| 09/30/2004 | CA2522176A1 Compositions useful as protein kinase inhibitors |
| 09/30/2004 | CA2520629A1 Methods of promoting the differentiation of stem cells |
| 09/30/2004 | CA2519458A1 Method for increasing the oral bioavailability of s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate |
| 09/30/2004 | CA2519412A1 Combined use of g-csf and factors having angiogenic action |
| 09/30/2004 | CA2519022A1 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound |
| 09/30/2004 | CA2519002A1 Phenylcarboxyl acid amides and ikr channel inhibitors combination and the use thereof for treating atrial arrhythmia |
| 09/30/2004 | CA2518227A1 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 09/29/2004 | EP1462518A1 Adipocyte differentiation-associated gene and protein |
| 09/29/2004 | EP1462105A1 Activation specific inhibitors of NF-kB and method of treating inflammatory processes in cardio-vascular diseases |
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461356A2 Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 09/29/2004 | EP1461347A1 2-o-(-d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 09/29/2004 | EP1461339A2 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/29/2004 | EP1461337A1 Pyrido[2,1-a]isoquinoline derivatives as dpp-iv inhibitors |
| 09/29/2004 | EP1461334A2 Pyrazole derived kinase inhibitors |
| 09/29/2004 | EP1461333A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461327A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461325A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461323A2 Compounds for the treatment of metabolic disorders |
| 09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 09/29/2004 | EP1461313A1 Human adam-10 inhibitors |
| 09/29/2004 | EP1461311A2 Urea derivatives as vr1-antagonists |
| 09/29/2004 | EP1461165A1 Metallic structures incorporating bioactive materials and methods for creating the same |
| 09/29/2004 | EP1461086A2 Enzymatic cleavable reagents for specific delivery to disease sites |
| 09/29/2004 | EP1461070A2 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 09/29/2004 | EP1461068A1 Methods of compositions for normalizing lipid levels in mammalian tissues |
| 09/29/2004 | EP1461067A1 Compositions and method for treating hepatitis virus infection |
| 09/29/2004 | EP1461057A1 A topical anti-itch formulation and a process for the preparation thereof |
| 09/29/2004 | EP1461043A1 Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation |
| 09/29/2004 | EP1461040A1 Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof |
| 09/29/2004 | EP1461039A1 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 09/29/2004 | EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/29/2004 | EP1461034A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines |
| 09/29/2004 | EP1461025A1 Treatment of neurodegenerative and cardiovascular disorders |
| 09/29/2004 | EP1460999A2 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 09/29/2004 | EP1460996A2 Novel-n-4-(1h-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1-h-pyrazole-5-carboxamides as factor xa |
| 09/29/2004 | EP1460995A1 Transdermal transport of compounds |
| 09/29/2004 | EP1389202B1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 09/29/2004 | EP1292288B1 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
| 09/29/2004 | EP1272180B1 Concentrated solutions of carvedilol |
| 09/29/2004 | EP1210320B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1202959B1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 09/29/2004 | EP1202957B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1200400B1 Substituted pyrrolidin-2,3,4-trion derivatives useful as nmda-receptor antagonists |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | EP1181278B1 Cyclic amine derivatives and their uses |
| 09/29/2004 | EP1176960B1 Synergistic combination comprising roflumilast and a pde-3 inhibitor |
| 09/29/2004 | EP1169302B1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 09/29/2004 | EP1123295B1 Bicyclic nitrogen heterocycles |
| 09/29/2004 | EP1114033B1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 09/29/2004 | EP1090019B1 Adenosine derivatives |
| 09/29/2004 | EP1067965B1 Pharmaceutical composition for treating cerebral apoplexy and craniocerebral trauma |
| 09/29/2004 | EP1062201B1 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
| 09/29/2004 | EP1003503B1 Therapeutic combinations comprising amlodipin and atorvastatin |
| 09/29/2004 | EP0999832B1 Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols |
| 09/29/2004 | EP0993439B1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 09/29/2004 | EP0969813B1 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 09/29/2004 | EP0914146B1 Morphogen treatment for chronic renal failure |
| 09/29/2004 | EP0901487B9 2,3,6 trisubstituted-4(3h)-quinazolinones |
| 09/29/2004 | CN1533431A Methods and reagents for cell transplantation |
| 09/29/2004 | CN1533399A 免疫调节肽 Immunomodulatory peptides |
| 09/29/2004 | CN1533392A Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 09/29/2004 | CN1533388A Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533292A Medicament inhititing sodium/calcium exchange system |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1533283A Use of osteopontin for treatment and/or prevention of neurologic diseases |
| 09/29/2004 | CN1533278A Naphtothiazine positive allosteric AMPA receptor modulators (PAARM) |
| 09/29/2004 | CN1533277A Preventives or remedies for diseases caused by e NOS expression |
| 09/29/2004 | CN1533276A Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 09/29/2004 | CN1533275A Use of 4-[(4-thiazolyl) phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 09/29/2004 | CN1533274A Benzofuranes and their use in treatment of artrial fibrillation |
| 09/29/2004 | CN1533271A 5-amino levulic acid as photosensitizer in ligh chemical therapy and cpmbination of its ester and another photosensitizer, and their use in therapy |
| 09/29/2004 | CN1533269A Carotenoids as anti-hypertension agents |
| 09/29/2004 | CN1531969A Brain protein hydrolysate freeze-drying powder injection and its preparing method |
| 09/29/2004 | CN1531966A Medicine for fumigating piles |
| 09/29/2004 | CN1531955A Heart replenishing capsule |
| 09/29/2004 | CN1531953A Method for preparing Diaoxinxuekang micro pill |
| 09/29/2004 | CN1531946A Formula and production process of angina pectoris medicine |
| 09/29/2004 | CN1531943A Formula and producing process of medicine for treating coronary heart disease and angina petoris |
| 09/29/2004 | CN1531930A Medicinal composition for curing cerebrovascular disease |
| 09/29/2004 | CN1531929A Brevis capine drip. pill and its preparing process |
| 09/29/2004 | CN1531928A Panaxitriol saponin preparation with biological activity and use |
| 09/29/2004 | CN1531926A Reinforced type lecithin capsule |
| 09/29/2004 | CN1531923A Use of all-trans vitamin A acid in preparing medicine for curing hypertension myocardial hypertrophy |
| 09/29/2004 | CN1168738C Biotin derivatives |
| 09/29/2004 | CN1168728C Pyrrolo-isoquinoline and tetrahydropyrrolko-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 09/29/2004 | CN1168727C Substituted benzimidazole |
| 09/29/2004 | CN1168726C Novel vitamin D analogues |
| 09/29/2004 | CN1168721C 5-cyano-2-aminopyrimidine derivatives |
| 09/29/2004 | CN1168720C Aryl alkanoylpyridazines compounds |
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168715C Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
| 09/29/2004 | CN1168712C Crystaline forms of sodium salt of 5-chloro-2-methoxy-N-(2(4- methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide |
| 09/29/2004 | CN1168711C Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |